» Authors » Maria Mercedes Santoro

Maria Mercedes Santoro

Explore the profile of Maria Mercedes Santoro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 108
Citations 797
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Petrone V, Scutari R, Malagnino V, Piermatteo L, Compagno M, Salpini R, et al.
Microbes Infect . 2025 Feb; :105478. PMID: 39894201
In the context of long-term therapy in virologically suppressed people living with HIV-1 (PLWH), the identification of new biomarkers associated with immuno-virological discordance, and the risk of disease progression is...
2.
Gouissi Anguechia D, Bouba Y, Ngoufack Jagni Semengue E, Kae A, Takou D, Ambe Chenwi C, et al.
Viruses . 2025 Jan; 16(12. PMID: 39772163
Dual therapies (DT) combining integrase strand transfer inhibitors (INSTIs) with second-generation non-nucleoside reverse transcriptase inhibitors (2nd-Gen-NNRTIs) offer new possibilities for HIV treatment to improve adherence. However, drug resistance associated mutations...
3.
Pipito L, Trizzino M, Mascarella C, Cannella S, Gaudiano R, Ganci I, et al.
J Glob Antimicrob Resist . 2024 Dec; 41:68-76. PMID: 39733833
Objectives: HIV-1 infection continues to be a significant public health concern, notwithstanding the expanded utilization of antiretroviral treatment (ART), due to the emergence of drug resistance. The prevalence of transmitted...
4.
Ambe Chenwi C, Nayang Mundo R, Nka A, Ngoufack Jagni Semengue E, Beloumou G, Kae A, et al.
J Int Assoc Provid AIDS Care . 2024 Dec; 23:23259582241306484. PMID: 39711049
Introduction: In low-and-middle-income-countries (LMIC), viral suppression is defined as plasma viral load (PVL) below 1000 copies/mL (low-level viremia [LLV]) and threshold for HIV drug resistance (HIVDR) testing. However, there is...
5.
Papaioannu Borjesson R, Zazzi M, Saladini F, Santoro M, Armenia D, Spagnuolo V, et al.
New Microbiol . 2024 Nov; 47(3):298-302. PMID: 39560045
Due to a limited range of effective treatment options, highly treatment-experienced (HTE) people with HIV (PWH) still struggle to maintain virological suppression and obtain an adequate immunological recovery. To increase...
6.
Ayokanmi M, Fokam J, Tchidjou H, Ambe Chenwi C, Hortense G, Kamgaing N, et al.
Curr HIV Res . 2024 Oct; 22(5):336-348. PMID: 39377407
Background: Virological failure (VF) among children remains concerning, with high risks of HIV drug resistance (HIVDR) emergence and increased disease progression. Therefore, monitoring of viral non-suppression and emerging HIVDR is...
7.
Togna Pabo W, Kengni Ngueko A, Nka A, Santoro M, Bouba Y, Ambe Chenwi C, et al.
Front Med (Lausanne) . 2024 Oct; 11:1457501. PMID: 39371336
Background: The elevated rate of AIDS-related mortality in Sub-Saharan Africa among adolescents living with HIV (ALHIV) is influenced by various factors, notably immunosuppression, within a framework of limited therapeutic alternatives....
8.
Bai F, Santoro A, Hedberg P, Tavelli A, De Benedittis S, Caporali J, et al.
Viruses . 2024 Sep; 16(9). PMID: 39339976
Post COVID-19 condition (PCC) is defined as ongoing symptoms at ≥1 month after acute COVID-19. We investigated the risk of PCC in an international cohort according to viral variants. We...
9.
Armenia D, Carioti L, Micheli V, Bon I, Allice T, Bonura C, et al.
Viruses . 2024 Sep; 16(9). PMID: 39339898
Background: Next-generation sequencing (NGS) is gradually replacing Sanger sequencing for HIV genotypic drug resistance testing (GRT). This work evaluated the concordance among different NGS-GRT interpretation tools in a real-life setting....
10.
Fokam J, Bouba Y, Ajeh R, Guebiapsi D, Essamba S, Zeh Meka A, et al.
Biomedicines . 2024 Sep; 12(9). PMID: 39335597
Mortality in children accounts for 15% of all AIDS-related deaths globally, with a higher burden among Cameroonian children (25%), likely driven by poor virological response. We sought to evaluate viral...